Age and generational patterns of overdose death risk from opioids and other drugs

被引:43
作者
Jalal, Hawre [1 ]
Buchanich, Jeanine M. [2 ]
Sinclair, David R. [1 ,3 ]
Roberts, Mark S. [1 ]
Burke, Donald S. [4 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA
[3] Newcastle Univ, Fac Med Sci, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA
基金
美国国家卫生研究院;
关键词
UNITED-STATES; MONITORING PROGRAMS; HEROIN; REDUCTIONS; FENTANYL; SIBLINGS; ABUSE;
D O I
10.1038/s41591-020-0855-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ongoing substance misuse epidemic in the United States is complex and dynamic and should be approached as such in the development and evaluation of policy(1). Drug overdose deaths (largely attributable to opioid misuse) in the United States have grown exponentially for almost four decades, but the mechanisms of this growth are poorly understood(2). From analysis of 661,565 overdose deaths from 1999 to 2017, we show that the age-specific drug overdose mortality curve for each birth-year cohort rises and falls according to a Gaussian-shaped curve. The ascending portion of each successive birth-year cohort mortality curve is accelerated compared with that of all preceding birth-year cohorts. This acceleration can be attributed to either of two distinct processes: a stable peak age, with an increasing amplitude of mortality rate curves from one birth-year cohort to the next; or a youthward shift in the peak age of the mortality rate curves. The overdose epidemic emerged and increased in amplitude among the 1945-1964 cohort (Baby Boomers), shifted youthward among the 1965-1980 cohort (Generation X), and then resumed the pattern of increasing amplitude in the 1981-1990 Millennials. These shifting age and generational patterns are likely to be driven by socioeconomic factors and drug availability, the understanding of which is important for the development of effective overdose prevention measures. A new age-period-cohort analysis reveals distinct generational patterns in deaths from opioid overdose in the United States, suggesting increased risks for Baby Boomers and Millennials.
引用
收藏
页码:699 / +
页数:11
相关论文
共 42 条
[1]  
Ahmad F, 2019, PROVISIONAL DRUG OVE
[2]   Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians [J].
Bao, Yuhua ;
Pan, Yijun ;
Taylor, Aryn ;
Radakrishnan, Sharmini ;
Luo, Feijun ;
Pincus, Harold Alan ;
Schackman, Bruce R. .
HEALTH AFFAIRS, 2016, 35 (06) :1045-1051
[3]   Premature mortality projections in the USA through 2030: a modelling study [J].
Best, Ana F. ;
Haozous, Emily A. ;
de Gonzalez, Amy Berrington ;
Chernyavskiy, Pavel ;
Freedman, Neal D. ;
Hartge, Patricia ;
Thomas, David ;
Rosenberg, Philip S. ;
Shiels, Meredith S. .
LANCET PUBLIC HEALTH, 2018, 3 (08) :E374-E384
[4]   Who are those "risk-taking adolescents"? Individual differences in developmental neuroimaging research [J].
Bjork, James M. ;
Pardini, Dustin A. .
DEVELOPMENTAL COGNITIVE NEUROSCIENCE, 2015, 11 :56-64
[5]   Management of opioid use disorder in the USA: present status and future directions [J].
Blanco, Carlos ;
Volkow, Nora D. .
LANCET, 2019, 393 (10182) :1760-1772
[6]  
Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150
[7]   Forecasting the opioid epidemic [J].
Burke, Donald S. .
SCIENCE, 2016, 354 (6312) :529-529
[8]   A unified approach for assessing heterogeneity in age-period-cohort model parameters using random effects [J].
Chernyavskiy, Pavel ;
Little, Mark P. ;
Rosenberg, Philip S. .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (01) :20-34
[9]   The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis [J].
Ciccarone, Daniel .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 71 :183-188
[10]   Fentanyl in the US heroin supply: A rapidly changing risk environment [J].
Ciccarone, Daniel .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 46 :107-111